Contract Service Directory


August Bioservices





Company Headquarters

1845 Elm Hill Pike
Nashville, TN 37210
United States

Company Description

As a growing, US-based CRO/CDMO, August offers extensive drug discovery, development and manufacturing services that advance our customers’ drug candidates from pre-clinical proof of concept to full commercialization. New for 2021: added commercial manufacturing capacity, lyophilization, terminal sterilization, and extractables and leachables testing.

Contract Service Directory

    Related Content

    • Bio News | Breaking News | Industry News
      August Bioservices Expands U.S. Biopharma Manufacturing Capabilities

      August Bioservices Expands U.S. Biopharma Manufacturing Capabilities

      $23.6 million investment from Polaris Partners will expand manufacturing capacity and capabilities to support production of sterile injectables.
      Tim Wright, Editor, Contract Pharma 05.27.21

    • August Bioservices Begins Major Expansion

      August Bioservices Begins Major Expansion

      To add large-scale lyophilization and sterile fill-finish capabilities to its clinical and commercial manufacturing offering.
      Contract Pharma Staff 08.20.20

    • Bio News | Breaking News | Industry News | Promotions & Moves
      PMI BioPharma Rebrands to August Bioservices

      PMI BioPharma Rebrands to August Bioservices

      Closes investment from Oak HC/FT to accelerate growth; Jenn Adams named chief executive officer.
      Contract Pharma Staff 07.17.20